• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XU Jianpei, XU Qunwei, WANG Xiaoqi, XIN Hongliang. Advances in biomimetic drug delivery systems based on platelet and platelet membrane[J]. Journal of China Pharmaceutical University, 2018, 49(6): 653-659. DOI: 10.11665/j.issn.1000-5048.20180603
Citation: XU Jianpei, XU Qunwei, WANG Xiaoqi, XIN Hongliang. Advances in biomimetic drug delivery systems based on platelet and platelet membrane[J]. Journal of China Pharmaceutical University, 2018, 49(6): 653-659. DOI: 10.11665/j.issn.1000-5048.20180603
shu

Advances in biomimetic drug delivery systems based on platelet and platelet membrane

More Information
    Graphical Abstract
    • Abstract
  • Platelet is an important component of human blood, which plays a key role in the physiological and pathological processes. Recently, novel drug delivery system based on platelet and platelet membrane bionics attracted much attention. Compared to the traditional drug carriers, platelet and platelet membrane-based biomimetic drug delivery system has great performances in biocompatibility, longer circulation and stronger ability of targeting. This review presented the features, classifications, drug-loading and applications of platelet and platelet membrane-based biomimetic drug delivery systems, promoting their development and application in the future.
    • FullText(HTML)
    • References (34)
  • [1]
    Rao L,Bu L,Xu J,et al.Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced acce-lerated blood clearance[J].Small,2016,11(46):6225-6236.
    [2]
    Pelaz B,Charron G,Pfeiffer C,et al.Interfacing engineered nanoparticles with biological systems:anticipating adverse nano-bio interactions[J].Small,2013,9(9/10):1573-1584.
    [3]
    Zhang FR,Wang W.Advances of synthetic lipoproteins as drug nanovectors[J].J China Pharm Univ(中国药科大学学报),2016,47(2):148-157.
    [4]
    Wang YZ,Zhou JP,Ding Y,et al.Advances in research of biomimetic drug delivery systems[J].J China Pharm Univ(中国药科大学学报),2014,43(3):267-273.
    [5]
    López J A,Berliner N.Introduction to a series of reviews on clinical platelet disorders[J].Blood,2017,129(21):2821-2822.
    [6]
    Nurden AT,Nurden P,Sanchez M,et al.Platelets and wound healing[J].Front Biosci,2008,13(13):3532-3548.
    [7]
    Semple JW,Jr IJ,Freedman J.Platelets and the immune continuum[J].Nat Rev Immunol,2011,11(4):264-274.
    [8]
    Cloutier N,Allaeys I,Marcoux G,et al.Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration[J].Proc Natl Acad Sci U S A,2018,115(7):1550-1559.
    [9]
    Münzer P,Borst O,Walker B,et al.Acid sphingomyelinase regulates platelet cell membrane scrambling,secretion,and thrombus formation[J].Arterioscler Thromb Vasc Biol,2014,34(1):61-71.
    [10]
    Jarre A,Gowert NS,Donner L,et al.Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer′s disease[J].Cell Signal,2014,26(9):2040-2050.
    [11]
    Zhao L, Thorsheim CL, Suzuki A, et al. Phosphatidylinositol transfer protein-α in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis[J].Nat Commun,2017,8(1):1216.
    [12]
    Nieswandt B,Watson SP.Platelet-collagen interaction:is GPVI the central receptor[J]?Blood,2003,102(2):449-461.
    [13]
    Wang C,Sun W,Ye Y,et al.In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy[J].Nat Biomed Eng,2017,1(2):0011.
    [14]
    Li J,Sharkey CC,Wun B,et al.Genetic engineering of platelets to neutralize circulating tumor cells[J].J Control Release,2016,228:38-47.
    [15]
    Xu P,Zuo H,Chen B,et al.Doxorubicin-loaded platelets as a smart drug delivery system:an improved therapy for lymphoma[J].Sci Rep,2017,7:42632.
    [16]
    Hu C MJ,Fang RH,Wang KC,et al.Nanoparticle biointerfacing by platelet membrane cloaking[J].Nature,2015,526(7571):118-121.
    [17]
    Lai C,Li C,Luo X,et al.Use of dual-ligand modification in Kupffer cell-targeted liposomes to examine the contribution of Kupffer cells to accelerated blood clearance phenomenon[J].Mol Pharm,2018,15(7):2548-2558.
    [18]
    Hu Q,Sun W,Qian C,et al.Anticancer platelet-mimicking nanovehicles[J].Adv Mater,2016,27(44):7043-7050.
    [19]
    Tesfamariam B.Involvement of platelets in tumor cell metastasis[J].Pharmacol Ther,2016,157:112-119.
    [20]
    Labelle M,Begum S,Hynes RO.Platelets guide the formation of early metastatic niches[J].Proc Natl Acad Sci U S A,2014,111(30):3053-3061.
    [21]
    Li J,Ai Y,Wang L,et al.Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles[J].Biomaterials,2016,76:52-65.
    [22]
    Sirotkina OV,Laskovets AB,Goldobin VV,et al.The molecular mechanisms of platelets activation in patients with cerebrovascular disease[J].Biomed Khim,2015,61(5):606-612.
    [23]
    Doshi N,Orje JN,Molins B,et al.Platelet mimetic particles for targeting thrombi in flowing blood[J].Adv Mater,2012,24(28):3864-3869.
    [24]
    Chang ST,Chung CM,Chu CM,et al.Platelet glycoprotein IIb/IIIa inhibitor tirofiban ameliorates cardiac reperfusion injury[J].Int Heart J,2015,56(3):335-340.
    [25]
    Hu Q, Qian C, Sun W, et al. Engineered Nanoplatelets for enhanced treatment of multiple myeloma and thrombus.[J].Adv Mater,2016,28(43):9573-9580.
    [26]
    Erickson PR,Herzberg MC.The Streptococcus sanguis platelet aggregation-associated protein.Identification and characterization of the minimal platelet-interactive domain[J].J Biol Chem,1993,268(3):1646-1649.
    [27]
    Corcoran PA,Atherton JC,Kerrigan SW,et al.The effect of different strains of Helicobacter pylori on platelet aggregation[J].Can J Gastroenterol,2007,21(6):367-370.
    [28]
    Kristinsson SY,Pfeiffer RM,Björkholm M,et al.Thrombosis is associated with inferior survival in multiple myeloma.[J].Haematologica,2012,97(10):1603-1607.
    [29]
    Li J,Angsantikul P,Liu W,et al.Biomimetic platelet-camouflaged nanorobots for binding and isolation of biological threats[J].Adv Mater,2018,30(2).doi: 10.1002/adma.201704800.
    [30]
    Mülfay V,Popa DP.International consensus report on the investigation and management of primary immune thrombocytopenia.[J].Blood,2010,115(2):168-186.
    [31]
    Wei X,Gao J,Fang RH,et al.Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia[J].Biomaterials,2016,111:116-123.
    [32]
    Modery-pawlowski CL,Tian LL,Ravikumar M,et al.In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct.[J].Biomaterials,2013,34(12):3031-3041.
    [33]
    Brown AC,Stabenfeldt SE,Ahn B,et al.Ultrasoft microgels displaying emergent platelet-like behaviours[J].Nat Mater,2014,13(12):1108-1114.
    [34]
    Zhang X,Wang J,Chen Z,et al.Engineering PD-1-presenting platelets for cancer immunotherapy[J].Nano Lett,2018,18(9):5716-5725.
    • Related Articles

  • Related Articles

    [1]LIU Mingxuan, GUO Yun, SUN Tao. Drug delivery systems for sensitization of glioblastoma radiotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 624-633. DOI: 10.11665/j.issn.1000-5048.2024050401
    [2]WANG Shihao, LIU Lifeng, DING Yang, LI Suxin. Research progress of pH-responsive drug delivery systems in cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 522-529. DOI: 10.11665/j.issn.1000-5048.2024011902
    [3]YU Jiayu, LIN Zezhi, CAO Wei, ZHANG Jianjun, WEI Yuanfeng, GAO Yuan, QIAN Shuai. Research progress of bio-metal organic frameworks in drug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 23-33. DOI: 10.11665/j.issn.1000-5048.20221111003
    [4]Gao Zhonghao. 新型药物递送系统技术在药物研发中的应用和展望[J]. Journal of China Pharmaceutical University, 2023, 54(1): 1-4. DOI: 10.11665/j.issn.1000-5048.2023030303
    [5]LI Haoxian, LIN Huaqing, CHEN Jingwen, WANG Liyuan. Research progress of carbon nanomaterials in cancer drug delivery[J]. Journal of China Pharmaceutical University, 2019, 50(1): 100-106. DOI: 10.11665/j.issn.1000-5048.20190114
    [6]CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
    [7]WANG Shu, ZHANG Zhenhai, GU Dongfei, ZHOU Jianping, LYV Huixia. Advances of exosomes as a new drug delivery system[J]. Journal of China Pharmaceutical University, 2014, 45(2): 247-252. DOI: 10.11665/j.issn.1000-5048.20140221
    [8]WU Qu, HUO Meirong, ZHOU Jianping. Advances on novel drug delivery system[J]. Journal of China Pharmaceutical University, 2013, 44(2): 97-104. DOI: 10.11665/j.issn.1000-5048.20130201
    [9]TANG Yue, KE Xue. Advances of mesoporous silica nanoparticles as drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(6): 567-572.
    [10]TANG Ji-hui, ZHOU Jian-ping, CHEN Fei-hu. Advances on the study of poly amino acid as drug carrier[J]. Journal of China Pharmaceutical University, 2011, 42(3): 284-288.

Catalog

    Get Citation
    PDF
    XML
    Article views (1007) PDF downloads (2033) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：415105

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return